We'd like to remind Forumites to please avoid political debate on the Forum... Read More »
📨 Have you signed up to the Forum's new Email Digest yet? Get a selection of trending threads sent straight to your inbox daily, weekly or monthly!
Investing in biotech stocks - My experience so far
Options
Comments
-
csgohan4 said:Looks like EVFM are in trouble, down to 1.22, from their high of 5$ earlier. Their earnings call at 1630 EST I doubt will improve things, their product has had some side effects with itching and I am not sure one product is going to be enough to save this company.
We shall see. I hope those invested will see the light of day, but sadly looks like the investment will be a loser on this occasionThe fascists of the future will call themselves anti-fascists.0 -
the earnings call is much better than expected
https://finance.yahoo.com/news/evofem-biosciences-reports-first-quarter-200100636.html
However there remains issues with the management board and the high overheads of over 40mil vs 1.1 revenue,
It is difficult to see which way this stock will go
I suspect alot of people will pump and dump in the short term on the back of the earnings call expectedly
If they make another stock offering, then this stock will be dead in the water as being an unsustainable company, no matter how good the product
This will remain a roller coaster ride
DYOR"It is prudent when shopping for something important, not to limit yourself to Pound land/Estate Agents"
G_M/ Bowlhead99 RIP1 -
csgohan4 said:the earnings call is much better than expected
https://finance.yahoo.com/news/evofem-biosciences-reports-first-quarter-200100636.html
However there remains issues with the management board and the high overheads of over 40mil vs 1.1 revenue,1 -
Anyone here invested in Avacta? They're up massively recently as market is expecting/hoping for them to be named as the sovereign test, and are due to release their affimer based covid LFT this month, some 6 months behind schedule. Redacted bidstats contract is a bit of a tease mentions mologic who are providing CE mark, and £1.5bn awarded to manufacturing partners alone. Will fully fund their cancer therapies in to stage 2 and beyond. Monday can't come soon enough!0
-
@BrockStoker
Any views on ARIX BIOSCIENCE (ARIX) ,
Came across this company the other day for the first time. More your speciality than mine. Interested me as UK based a rare find.1 -
jjdc said:Anyone here invested in Avacta? They're up massively recently as market is expecting/hoping for them to be named as the sovereign test, and are due to release their affimer based covid LFT this month, some 6 months behind schedule. Redacted bidstats contract is a bit of a tease mentions mologic who are providing CE mark, and £1.5bn awarded to manufacturing partners alone. Will fully fund their cancer therapies in to stage 2 and beyond. Monday can't come soon enough!
Yes. As well as ARWR, AMRS and EVFM, I also have some Avacta which is looking the most promising of the 4 in the short term.
0 -
csgohan4 said:the earnings call is much better than expected
https://finance.yahoo.com/news/evofem-biosciences-reports-first-quarter-200100636.html
However there remains issues with the management board and the high overheads of over 40mil vs 1.1 revenue,
It is difficult to see which way this stock will go
I suspect alot of people will pump and dump in the short term on the back of the earnings call expectedly
If they make another stock offering, then this stock will be dead in the water as being an unsustainable company, no matter how good the product
This will remain a roller coaster ride
DYOR
It defiantly wants to go up, but I'm guessing downward pressure from shorts is holding it back for the moment. Can only hope that the bulls/longs win, but as you say, it's bound to be a roller coaster for a while yet.
0 -
jjdc said:Anyone here invested in Avacta? They're up massively recently as market is expecting/hoping for them to be named as the sovereign test, and are due to release their affimer based covid LFT this month, some 6 months behind schedule. Redacted bidstats contract is a bit of a tease mentions mologic who are providing CE mark, and £1.5bn awarded to manufacturing partners alone. Will fully fund their cancer therapies in to stage 2 and beyond. Monday can't come soon enough!I'm weary of all cancer stocks, so would not invest. I believe Arrowhead/RNAi already has the answer/cure for cancer, where as small molecule drugs are at a significant disadvantage relative to Arrowhead/RNAi. We should have a better idea if I'm right in the next 2-4 months. Of course, even if ARO-HIF2 shows great data, I doubt all other cancer stocks will fall immediately, but they may do over the coming years as the realization starts to sink in that Arrowhead should be able to tackle may different types of cancer effectively.It might be worth considering hedging your bets by picking up some ARWR. ARWR has huge potential in all areas, not just cancer, and now is a good time to buy with 9 catalysts due over the summer - I doubt it will ever be this chap again.0
-
Thrugelmir said:@BrockStoker
Any views on ARIX BIOSCIENCE (ARIX) ,
Came across this company the other day for the first time. More your speciality than mine. Interested me as UK based a rare find.
0 -
BrockStoker said:Thrugelmir said:@BrockStoker
Any views on ARIX BIOSCIENCE (ARIX) ,
Came across this company the other day for the first time. More your speciality than mine. Interested me as UK based a rare find.
https://www.fundslibrary.co.uk/FundsLibrary.DataRetrieval/Documents.aspx/?type=sl.ra.full&id=7fb9ab3e-c003-4347-a780-dcaa2fd05b63&user=8Ntr%2fH%2fAGAzOkOywqrKV5lHeWQytHLkBh1MOjgrLILodXp9DGCM74Jrkj5tTb7Y2&r=1
The fascists of the future will call themselves anti-fascists.1
Confirm your email address to Create Threads and Reply

Categories
- All Categories
- 351.2K Banking & Borrowing
- 253.2K Reduce Debt & Boost Income
- 453.7K Spending & Discounts
- 244.2K Work, Benefits & Business
- 599.2K Mortgages, Homes & Bills
- 177K Life & Family
- 257.6K Travel & Transport
- 1.5M Hobbies & Leisure
- 16.1K Discuss & Feedback
- 37.6K Read-Only Boards